65 filings
Page 2 of 4
8-K
3ishyuvgebr
14 Jun 22
Submission of Matters to a Vote of Security Holders
4:59pm
8-K
qramei u5gw
25 Mar 22
Departure of Directors or Certain Officers
5:23pm
8-K
7u4j3
15 Feb 22
ImmunityBio Completes Acquisition of Athenex’s Interest in Dunkirk, New York Advanced
9:00am
8-K
vom 9zwkojf
12 Jan 22
Entry into a Material Definitive Agreement
8:35am
8-K
p2ab2
20 Dec 21
Immunitybio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of Covid
9:07am
8-K
g0qehgf14jx92uix
27 Sep 21
Entry into a Material Definitive Agreement
8:46am
8-K
bnbiiv4iyczf
13 Sep 21
Results of Operations and Financial Condition
8:37am
8-K
xbukc ksw
13 Aug 21
Departure of Directors or Certain Officers
4:16pm
8-K
xx10b
15 Jun 21
Submission of Matters to a Vote of Security Holders
7:11am
8-K
cv5nl
11 Jun 21
Results of Operations and Financial Condition
5:18pm
8-K
2op9 1qzi
4 Jun 21
Regulation FD Disclosure
8:30am
8-K
d2n2 raihc
28 May 21
Entry into a Material Definitive Agreement
4:08pm
8-K
x1yvzie74bwuo
3 May 21
Entry into a Material Definitive Agreement
6:06am
8-K/A
e8fru14zbch1unba3jr6
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K
rb7r4ydg
1 Apr 21
ImmunityBio Appoints Dr. Linda Maxwell and CEO Richard Adcock to Board of Directors
9:15am
8-K
xvmpu
17 Mar 21
Regulation FD Disclosure
5:24pm
8-K
zthxwe pd
9 Mar 21
ImmunityBio and NantKwest Complete Merger
9:58pm
8-K
qpfz dv76x3s8g
25 Feb 21
Other Events
5:15pm
8-K
n74n9p jqgqr1l
24 Feb 21
ImmunityBio Appoints John Brennan and Wesley Clark to Board of Directors
4:59pm
8-K
t270 6qdmn9503tmbkk
10 Feb 21
Departure of Directors or Certain Officers
4:38pm